IntroductionEvery year, many people die due to cancer in all of the world. So, the preparation and formulation of new chemotherapeutic supplements and drugs with remarkable effects to treat cancer are the priority of both developing and developed countries. In this study, zinc nanoparticles were synthesized in an aqueous medium using Fumaria officinalis leaf as stabilizing and reducing agents.Material and methodsThe green synthesized ZnNPs@ Fumaria officinalis were characterized using different techniques including UV-visible and FT-IR spectroscopy, X‐ray diffraction (XRD), scanning electron microscopy (SEM), and Energy Dispersive X-ray Spectrometry (EDS). The anticancer activity of ZnNPs@ Fumaria officinalis was evaluated against acute myeloid leukemia and acute T cell leukemia.ResultsAccording to the XRD analysis, 20.44 nm was measured for the crystal size of the nanoparticles. SEM images showed a uniform spherical morphology with an average size of 27.96 nm for ZnNPs@ Fumaria officinalis. In the cellular and molecular part of the recent study, the treated cells with ZnNPs@Fumaria officinalis were assessed by MTT assay for 48h about the cytotoxicity and anti-human acute leukemia properties on normal (HUVEC), acute myeloid leukemia (32D-FLT3-ITD and Human HL-60/vcr), and acute T cell leukemia (Jurkat, Clone E6-1 and J.RT3-T3.5) cell lines. The IC50 of ZnNPs@Fumaria officinalis were 227, 200, 250, and 336 µg/mL against 32D-FLT3-ITD, Human HL-60/vcr, Jurkat, Clone E6-1, and J.RT3-T3.5 cell lines, respectively.ConclusionsThe viability of malignant leukemia cell line reduced dose-dependently in the presence of ZnNPs@Fumaria officinalis. It appears that the anti-human acute leukemia effect of ZnNPs@Fumaria officinalis is due to their antioxidant effects.
Acute Myeloid Leukemia Diagnosed 5 Years after Adult T-Cell Leukemia/Lymphoma